Subsection
Public Health & Environment sits under Lifestyle & Home Wellness . Population-level exposures — air, water, heat, and infection — and what they mean at home.
12 stories
Columbia researchers found 47% of 9/11 first responders developed COPD-like obstructive lung disease 25+ years after exposure. Here's the screening protocol and prevention strategies.
New ProPublica investigation finds elevated NO₂ and asthma rates near data center clusters in Northern Virginia. Learn about diesel emissions, mitigation strategies, and whether your home is at risk.
The FDA approved daraxonrasib in August 2026, and patients in the pivotal trial lived twice as long as those on chemo. The price tag, however, is roughly $480,000 a year. Here is who qualifies, how the drug works, and what the cost really means.
President Trump nominated Dr. Heidi Overton, a top domestic policy aide and MAHA-aligned abortion opponent, to be the next FDA Commissioner. If confirmed, she will inherit a backlog of decisions on supplements, GLP-1 compounding, and pediatric vaccines. Here is what is likely to change and what is not.
In August 2026, Pennsylvania confirmed two measles deaths. The CDC Director publicly challenged the state's count, Health Secretary RFK Jr. issued mixed messaging, and the clash exposed the fracture between federal and state public-health authority.
Moderna's mRNA-4157 plus Merck's Keytruda cut the risk of melanoma recurrence by about half in high-risk patients in 2024. The 2026 update from ASCO and a phase 3 trial expansion show the approach is moving toward broader approval. Here is the science, the trial, and what to expect.
The 2026 ACS guideline added a blood test and a new RNA stool test to colon cancer screening. We explain how Shield, Cologuard, FIT, and colonoscopy compare — and where the blood test falls short.
Long COVID affects millions, but proven treatments are scarce. We explain the 2026 evidence on pacing, the failed Paxlovid and metformin treatment trials, and prevention that actually works.
Updated flu and COVID shots are expected this fall with insurer coverage despite a stalled federal advisory committee. Here is what to do right now.
In 2026 HHS moved flu, COVID, HepA, HepB, meningococcal, and rotavirus off the universal recommendation list. Here is what changed, what stays covered, and what parents should do.
Shingrix has long been recommended from age 50, but more younger adults with risk factors are getting it. Here is who should consider it and why timing matters.
The EPA issued new interim guidance on PFAS destruction and disposal in April 2026, and NRDC warned that PFAS microplastics are a global contaminant found in human blood, placenta, lung tissue, and semen. Here is what to do now.
More from Lifestyle & Home Wellness .
